Grant: Alliance Grants
University of Windsor
$30,000.00
Relative antimicrobial potential of soluble aqueous ozone at different concentrations vs. standard of care disinfectants
FY 2023-24
Summary
Windsor, Ontario-based Tersano Inc is one of the world's leading manufacturers and designers of instruments to provide soluble aqueous ozone (SAO). SAO is a human-safe alternative to harsher more persistent cleaning products as, like bleach or detergents, it sterilizes surfaces, but unlike them, the active agent, ozone, is an unstable gas that rapidly decomposes to oxygen and evaporates away. This isn't just a problem for cleaning, it's a problem in surgery too. When operating, the medical team needs to make sure that no bacteria can grow in the wound or on implantable devices like stents or replacement joints. The chemicals currently used have been largely grandfathered in and lack the rigorous safety data we would expect! More importantly, they stay in the body when the surgery is over, only being slowly cleared. A slow stream of SAO might accomplish the same effect but with less damage to the wound, and evaporate and dissipate rapidly after the surgery. This could make recovery easier and safer, while ensuring that wounds do not get infected. In this study, the partners are looking at how well SAO does compared to the standard therapies using model systems to kill bacteria. They are also looking at how toxic these two regimes are to human cells using 3-D bioprinted models. This will provide information about the efficacy of the current therapies, and SAO and help Tersano provide a better solution to surgeons and patients in the future. This 1-year project deepens the relationship between Tersano and the team at the University of Windsor, and looks forward to bringing these tools into the hands of practitioners.
Program
Alliance Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
581070-2022
Name nom
Trant, John JF
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3400
Research subject group en
Physical chemistry
Research subject group fr
Physical chemistry
Research subject en
Chimie physique
Research subject fr
Chimie physique
Application title
Relative antimicrobial potential of soluble aqueous ozone at different concentrations vs. standard of care disinfectants
Keyword
antibacterial activity; antisepsis; biofilm; ex vivo models; fungicidal activity; in vitro models; ozone
Application summary
Windsor, Ontario-based Tersano Inc is one of the world's leading manufacturers and designers of instruments to provide soluble aqueous ozone (SAO). SAO is a human-safe alternative to harsher more persistent cleaning products as, like bleach or detergents, it sterilizes surfaces, but unlike them, the active agent, ozone, is an unstable gas that rapidly decomposes to oxygen and evaporates away. This isn't just a problem for cleaning, it's a problem in surgery too. When operating, the medical team needs to make sure that no bacteria can grow in the wound or on implantable devices like stents or replacement joints. The chemicals currently used have been largely grandfathered in and lack the rigorous safety data we would expect! More importantly, they stay in the body when the surgery is over, only being slowly cleared. A slow stream of SAO might accomplish the same effect but with less damage to the wound, and evaporate and dissipate rapidly after the surgery. This could make recovery easier and safer, while ensuring that wounds do not get infected. In this study, the partners are looking at how well SAO does compared to the standard therapies using model systems to kill bacteria. They are also looking at how toxic these two regimes are to human cells using 3-D bioprinted models. This will provide information about the efficacy of the current therapies, and SAO and help Tersano provide a better solution to surgeons and patients in the future. This 1-year project deepens the relationship between Tersano and the team at the University of Windsor, and looks forward to bringing these tools into the hands of practitioners.